Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Ziegelbauer
A Novel Selective Small-Molecule PI3K Inhibitor Is Effective Against Human Multiple Myeloma in Vitro and in Vivo
Blood Cancer Journal
Oncology
Hematology
Related publications
COTI-2, a Novel Small Molecule That Is Active Against Multiple Human Cancer Cell Lines in Vitro and in Vivo
Oncotarget
Oncology
A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget
Oncology
Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Correction: A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth in Vitro and in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo
Oncology Letters
Cancer Research
Oncology
In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma
Haematologica
Hematology
Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule Inhibitor
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research
Cancer Research
Oncology
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence
Clinical Cancer Research
Cancer Research
Oncology